European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update (Q46050924)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

Raoul Herbrecht

object named as

R Herbrecht

3

0 references

author name string

J Maertens

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

O Marchetti

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

O A Cornely

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

U Flückiger

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

P Frêre

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

B Gachot

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

W J Heinz

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

C Lass-Flörl

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

P Ribaud

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

A Thiebaut

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

C Cordonnier

12

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

Third European Conference on Infections in Leukemia

13

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

language of work or name

0 references

publication date

26 July 2010

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

Bone Marrow Transplantation

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

46

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

709-718

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

https://scigraph.springernature.com/pub.10.1038/bmt.2010.175

0 references

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Empirical antifungal therapy in selected patients with persistent febrile neutropenia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

21 January 2018

Primary antifungal prophylaxis in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Guide to development of practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.175

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2010.175

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/20661235

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46050924&oldid=2089568071"